"Designing Growth Strategies is in our DNA"
The U.S. microsurgery market size was worth USD 871.9 million in 2022 and is projected to grow at a CAGR of 5.6% during the forecast period.
The U.S. has seen a significant rise in the prevalence of chronic diseases, which is anticipated to increase the demand for microsurgical procedures in the country. Chronic conditions, such as cancer, diabetes, and cardiovascular diseases, require microsurgery treatment for reconstruction or limb salvage. For instance, according to the Journal of the American Medical Association, in July 2023, approximately 1.6 million individuals each year were affected by diabetic foot ulcers in the U.S.
Furthermore, the availability of skilled microsurgical and complex fracture expertise for patients who are at high risk of limb amputation in the U.S. increases the adoption of microsurgical products. This boosts the country's market growth.
The influence of the COVID-19 resulted in lower demand for microsurgery in 2020. The negative impact was due to a decrease in the volume and demand for minimally invasive surgeries in the country. For instance, according to the American Society of Plastic Surgeons, in April 2020, the society boards-certified plastic surgeons stopped performing elective surgical procedures for an average of 8.1 weeks in 2020 due to the pandemic, or 15% of the year, which reflects the decline in the total number of procedures performed in 2020. However, after the relaxation of the lockdown in the country, the microsurgeries regained their momentum.
Innovations in Microsurgeries is a Significant Trend
The technologically advanced nature of microsurgery products drives the increasing number of microsurgery procedures due to their various advantages, such as minimal blood loss, better stereoscopic vision during minimally invasive surgeries, reduced efforts & time of the surgeons, and improved physical comfort.
Furthermore, the involvement of prominent players in the country in developing new microsurgical instruments and increasing investments contributes to market growth, shifting surgeons' preference for these technologically superior products.
In such a way, technological advancements in robotics significantly boost the U.S. microsurgery market growth.
Surging Incidence of Injuries to Augment Market Growth
The rising cases of accidents and other fatal injuries are some of the significant drivers for the U.S. market. These rising cases increase the number of patients who require these treatments.
Such growing cases of fatal work-related injuries and increasing awareness about these procedures significantly contribute to the adoption of these products in the U.S. Furthermore, the soft tissue injuries that require microsurgery treatment are the primary reason contributing to the rise in demand for microsurgical devices in the country.
Request a Free sample to learn more about this report.
In the U.S., according to the American Association of Medical Colleges, there were 18,948.0 active ophthalmology physicians and 9,616.0 otolaryngology physicians in 2021.
Lack of Reimbursement and High Costs of Microsurgical Procedures to Hamper Market Growth
The lack of reimbursement policies in the U.S. hinders the individuals' adoption of expensive surgical procedures, including microsurgery, by healthcare facilities. Hence, the increase in the gap between individual and microsurgical treatments is expected to lower the adoption of microsurgical devices in the country.
Moreover, the high cost of microsurgical procedures resulting in out-of-pocket spending is likely expected to limit the adoption of operating microscopes utilized in microsurgery. In such a way, the higher costs and limited reimbursement hinder the U.S. market growth.
Based on product type, the U.S. market is bifurcated into microsurgical instruments and operating microscopes. The microsurgical instruments are further subdivided into microscissors & microforceps, microsutures, and others.
The microsurgical instruments segment accounted for the largest U.S. microsurgery market share and is anticipated to grow at the highest CAGR during the forecast period due to its efficiency, minimal tissue trauma, force-free incisions, and better surgical outcomes that offer several advantages for surgical microscopes. Additionally, the growing number of aged individuals, which requires more complex surgeries, increases the adoption of microsurgical instruments and surges the segment growth.
Moreover, the increasing use of microscissors & microforceps due to their ease of use and minimal scarring drives the microsurgical instruments segment growth.
In 2022, operating microscopes held a substantial market share. The growth is due to the rising cases of minimally invasive surgeries, and increasing adoption of minimally invasive techniques necessitating high-quality visualization tools.
Based on application, the U.S. market is segmented into plastic surgery, ophthalmology surgery, neuro & spine surgery, otolaryngology surgery, and others.
The ophthalmology surgery segment held the largest market share in 2022. Key companies emphasize innovating new and technologically superior products in the market. These advancements enable more precise and minimally invasive procedures for eye conditions, which is expected to drive the preference for microsurgery in the market. Moreover, the rising cases of cataract extraction also fuel the demand for microsurgery in the U.S. market.
The neuro & spine surgery segment is anticipated to grow at the strongest CAGR during 2023-2030 due to the increasing use of operating microscopes in minimally invasive surgeries in the U.S.
In terms of the segment of end-user, the U.S. market is segmented into hospitals, specialty clinics, and others.
The hospitals segment accounted for the largest share in 2022. The growth is attributed to the rising patient population who visits hospitals for various microsurgical procedures. Moreover, the hospitals have more resources and advanced equipment compared to specialty clinics, enable to perform a wider range of medical procedures, including microsurgeries.
The specialty clinics segment is estimated to grow at the highest CAGR during the forecast period. The increasing focus on research using microscopes in surgeries is driving the segment growth. Moreover, specialty clinics often have microsurgeons specializing in hand surgery and cosmetic surgeries such as plastic surgeries, which are anticipated to propel segmental growth.
In terms of the competitive landscape, Baxter, Carl Zeiss Meditech AG, and Stryker are the major market players operating in the U.S market. These companies are actively involved in research and development with an aim to introduce highly effective and advanced surgical microscopes. Furthermore, a strong focus on collaborations and acquisitions with other prominent players and research institutes to integrate new technology and develop new microsurgical devices boosts the market share of these companies.
Some other companies have a significant presence in the U.S. market, such as Leica Microsystems, Aesculap, Inc., Corza Medical, and other domestic companies. These companies are concentrating on strategic initiatives, such as entering into collaborations and launching advanced products to strengthen their product portfolios, which is expected to attract more market shares.
An Infographic Representation of U.S. Microsurgery Market
To get information on various segments, share your queries with us
The U.S. microsurgery market report covers a detailed analysis of the competitive landscape in the market. It includes data such as prevalence of key diseases and volume of injury cases in the country. Additionally, it covers technological advancements, and key industry developments and new product launches in the U.S. market. Also, the report focuses on the COVID-19 impact on the U.S. market.
To gain extensive insights into the market, Request for Customization
ATTRIBUTE | DETAILS |
Study Period | 2019-2030 |
Base Year | 2022 |
Estimated Year | 2023 |
Forecast Period | 2023-2030 |
Historical Period | 2019-2021 |
Growth Rate | CAGR of 5.6% from 2023 to 2030 |
Unit | Value (USD Million) |
Segmentation | By Product Type
|
By Application
| |
By End-user
|
Fortune Business Insights says that the U.S. market was worth USD 871.9 million in 2022.
The market is expected to exhibit a CAGR of 5.6% during the forecast period (2023-2030).
By product type, the microsurgical instruments segment accounted for the largest share of the market.
Baxter, Carl Zeiss Meditech AG, and Stryker are the top players in the market.
Related Reports
US +1 833 909 2966 ( Toll Free )